Edmonton, Canada

Rong Ling

This inventor holds 14 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Fedora Pharmaceuticals Inc., Apoapsis Holdings, LLC, Corteva Agriscience LLC. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rong Ling. Retrieved from https://idiyas.com/inventor/rong-ling

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 78.6

 

 

Average Co-Inventor Count = 4.9

ph-index = 4

Forward Citations = 60(Granted Patents)


Location History:

  • Alberta, CA (2017 - 2020)
  • Edmonton, CA (2014 - 2024)

Company Filing History:


Years Active: 2014-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
MDMA Compounds
Psychoactive Agents
Bicyclic Compounds
Antibacterial Agents
Beta-Lactamase Inhibitors
Cephem Compounds
Halogen Analogs
Synthesis Methods
14 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Rong Ling

Introduction

Rong Ling is a notable inventor based in Edmonton, Canada, recognized for his significant contributions to the field of chemistry. With a total of 11 patents to his name, he has made remarkable advancements in the development of chemical compounds and processes.

Latest Patents

Among his latest patents, Rong Ling has developed methods for the preparation of halogen analogs of picloram. These methods involve a series of chemical process steps that include introducing a phthaloyl group onto the 4-amino substituent of picloram, adding fluorine atoms at specific positions using halex fluorination chemistry, and subsequently modifying the resulting compounds. Additionally, he has focused on short-acting psychoactive compounds of the MDMA class, creating novel chemical compositions that feature substituted methylenedioxyphenethylamine and substituted amphetamine with a metabolically labile thioether group.

Career Highlights

Rong Ling has worked with several prominent companies in the pharmaceutical industry, including Fedora Pharmaceuticals Inc. and Naeja Pharmaceutical Inc. His work in these organizations has contributed to the advancement of innovative chemical solutions and therapeutic compounds.

Collaborations

Throughout his career, Rong Ling has collaborated with esteemed colleagues such as Samarendra N Maiti and Dai Q Nguyen. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of chemistry.

Conclusion

Rong Ling's innovative work and numerous patents highlight his significant impact on the field of chemistry. His contributions continue to influence the development of new chemical compounds and processes, showcasing his dedication to advancing scientific knowledge.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…